Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etelcalcetide vs Cinacalcet in Asian Hemodialysis Patients with SHPT
NCT03299244Phase 3Completed
- Sponsor
- Amgen
- Start
- May 2018
- Primary completion
- Apr 2020
- Modality
- Peptides, Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of etelcalcetide in secondary hyperparathyroidism (SHPT), sponsored by Amgen. Started May 2018; status: completed.
02
Drugs
etelcalcetide
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT03299244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03299244.